Literature DB >> 29674474

Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in Il19-/-×Ldlr-/- Double Knockout Mice by Dysregulation of mRNA Stability Protein HuR (Human Antigen R).

Mitali Ray1, Khatuna Gabunia1, Christine N Vrakas1, Allison B Herman1, Farah Kako1, Sheri E Kelemen1, Laurel A Grisanti2, Michael V Autieri3.   

Abstract

OBJECTIVE: To test the hypothesis that loss of IL-19 (interleukin-19) exacerbates atherosclerosis. APPROACH AND
RESULTS: Il19-/- mice were crossed into Ldlr-/- (low-density lipoprotein receptor knock out) mice. Double knockout (dKO) mice had increased plaque burden in aortic arch and root compared with Ldlr-/- controls after 14 weeks of high-fat diet (HFD). dKO mice injected with 10 ng/g per day rmIL-19 had significantly less plaque compared with controls. qRT-PCR and Western blot analysis revealed dKO mice had increased systemic and intraplaque polarization of T cells and macrophages to proinflammatory Th1 and M1 phenotypes, and also significantly increased TNF (tumor necrosis factor)-α expression in spleen and aortic arch compared with Ldlr-/- controls. Bone marrow transplantation suggests that immune cells participate in IL-19 protection. Bone marrow-derived macrophages and vascular smooth muscle cells isolated from dKO mice had a significantly greater expression of inflammatory cytokine mRNA and protein compared with controls. Spleen and aortic arch from dKO mice had significantly increased expression of the mRNA stability protein HuR (human antigen R). Bone marrow-derived macrophage and vascular smooth muscle cell isolated from dKO mice also had greater HuR abundance. HuR stabilizes proinflammatory transcripts by binding AU-rich elements in the 3' untranslated region. Cytokine and HuR mRNA stability were increased in dKO bone marrow-derived macrophage and vascular smooth muscle cell, which was rescued by addition of IL-19 to these cells. IL-19-induced expression of miR133a, which targets and reduced HuR abundance; miR133a levels were lower in dKO mice compared with controls.
CONCLUSIONS: These data indicate that IL-19 is an atheroprotective cytokine which decreases the abundance of HuR, leading to reduced inflammatory mRNA stability.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; bone marrow; cytokines; endothelial cells; macrophages

Mesh:

Substances:

Year:  2018        PMID: 29674474      PMCID: PMC5970062          DOI: 10.1161/ATVBAHA.118.310929

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  37 in total

1.  Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.

Authors:  Anthony A Cuneo; David Herrick; Michael V Autieri
Journal:  J Mol Cell Cardiol       Date:  2010-05-06       Impact factor: 5.000

Review 2.  Control of cytokine mRNA expression by RNA-binding proteins and microRNAs.

Authors:  V Palanisamy; A Jakymiw; E A Van Tubergen; N J D'Silva; K L Kirkwood
Journal:  J Dent Res       Date:  2012-02-01       Impact factor: 6.116

3.  Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR.

Authors:  Rudolf Pullmann; Magdalena Juhaszova; Isabel López de Silanes; Tomoko Kawai; Krystyna Mazan-Mamczarz; Marc K Halushka; Myriam Gorospe
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

Review 4.  Modulation of mRNA stability as a novel therapeutic approach.

Authors:  Wolfgang Eberhardt; Anke Doller; El-Sayed Akool; Josef Pfeilschifter
Journal:  Pharmacol Ther       Date:  2007-01-25       Impact factor: 12.310

Review 5.  Post-transcriptional control of cytokine production.

Authors:  Paul Anderson
Journal:  Nat Immunol       Date:  2008-04       Impact factor: 25.606

Review 6.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

7.  Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.

Authors:  Ching-Hua Yeh; Bor-Chih Cheng; Chuan-Chih Hsu; Hung-Wei Chen; Jhi-Joung Wang; Ming-Shi Chang; Chung-Hsi Hsing
Journal:  Ann Thorac Surg       Date:  2011-10       Impact factor: 4.330

Review 8.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

9.  Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC.

Authors:  Khatuna Gabunia; Allison B Herman; Mitali Ray; Sheri E Kelemen; Ross N England; Raul DeLa Cadena; William J Foster; Katherine J Elliott; Satoru Eguchi; Michael V Autieri
Journal:  J Mol Cell Cardiol       Date:  2017-02-28       Impact factor: 5.000

10.  Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis.

Authors:  Stephanie Schulte; Galina K Sukhova; Peter Libby
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

View more
  17 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

2.  Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis.

Authors:  Allison B Herman; Milessa Silva Afonso; Sheri E Kelemen; Mitali Ray; Christine N Vrakas; Amy C Burke; Rosario G Scalia; Kathryn Moore; Michael V Autieri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

3.  Updates on Approaches for Studying Atherosclerosis.

Authors:  Congqing Wu; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

Review 4.  Resolution of inflammation in immune and nonimmune cells by interleukin-19.

Authors:  Tani Leigh; Rosario G Scalia; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-15       Impact factor: 5.282

5.  Deletion of LDLRAP1 Induces Atherosclerotic Plaque Formation, Insulin Resistance, and Dysregulated Insulin Response in Adipose Tissue.

Authors:  Tani Leigh; Tatsuo Kawai; Kyle Preston; Sheri Kelemen; Rachael Okune; Amanda St Paul; Cali Corbett; Amanda M Peluzzo; Jun Yu; Rosario G Scalia; Michael V Autieri
Journal:  Am J Pathol       Date:  2022-04-20       Impact factor: 5.770

Review 6.  Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-23       Impact factor: 8.311

7.  RNA stability protein ILF3 mediates cytokine-induced angiogenesis.

Authors:  Christine N Vrakas; Allison B Herman; Mitali Ray; Sheri E Kelemen; Rosario Scalia; Michael V Autieri
Journal:  FASEB J       Date:  2018-11-01       Impact factor: 5.834

Review 8.  The crosstalk of ABCA1 and ANXA1: a potential mechanism for protection against atherosclerosis.

Authors:  Xin Shen; Shun Zhang; Zhu Guo; Dongming Xing; Wujun Chen
Journal:  Mol Med       Date:  2020-09-07       Impact factor: 6.354

9.  Cardiovascular disease, inflammation, and mRNA stability.

Authors:  Allison B Herman; Michael V Autieri
Journal:  Aging (Albany NY)       Date:  2018-10-26       Impact factor: 5.682

Review 10.  Impact of miRNA in Atherosclerosis.

Authors:  Yao Lu; Tanuja Thavarajah; Wenduo Gu; Jingjing Cai; Qingbo Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.